Jiang Rensheng & family (#830)
- $ 5 B
- Vaccines
- China
- M
- 72 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Jiang Rensheng is the chairman of Shenzhen-listed vaccine firm Chongqing Zhifei Biological Products. A longtime distribution partner of Merck, Zhifei won the Chinese sales rights to the U.S. pharma's HPV drug in 2018. In 2023, Jiang took his antibody drug maker Chongqing Genrix Biopharmaceutical public on the Shanghai Stock Exchange. Prior to striking out on his own, he worked as a primary school teacher and a government health official.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Jiang Rensheng & family’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Jiang Rensheng & family’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $5.1B
(May 4, 2026)
© Iconic Billionaires